Corvus Pharmaceuticals, Inc. (CRVS)
7.94
-0.45
(-5.36%)
USD |
NASDAQ |
Dec 16, 16:00
8.04
+0.10
(+1.26%)
Pre-Market: 08:30
Corvus Pharmaceuticals Shareholders Equity (Quarterly): 71.77M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
| Oragenics, Inc. | 9.831M |
| NanoViricides, Inc. | 7.175M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.47M |
| Total Liabilities (Quarterly) | 8.706M |
| Debt to Equity Ratio | 0.0141 |
| Current Ratio | 8.291 |
| Net Debt Paydown Yield | -0.01% |